Clinical research of different ventilation modes combined with pulmonary surfactant and ;mucosolvan in the treatment of preterm newborns with hyaline membrane disease
Author(s): Wu Jiebin, Zhou Bin, Zhai Jingfang, Jin Bao, Zhang Yanyan
Pages: 3704-3708
Year: 2015 Issue: 20
Journal: Chinese Journal of Clinicians(Electronic Version)
Keyword: Respiration; artificial; Hyaline membrane disease; High frequency oscillatory ventilation; Pulmonary surfactant; Mucosolvan; Preterm newborns;
Abstract: Objective To investigate the clinical application effect of different ventilation modes combined with pulmonary surfactant and mucosolvan in the treatment of preterm newborns with hyaline membrane disease (HMD). Methods 76 cases of preterm infants with HMD (Ⅲ-Ⅳgrade) from Xuzhou central hospital neonatal intensive care unit (neonatal intensive care unit, NICU) from 2013 January to 2015 February were randomly divided into two group, high frequency oscillatory ventilation (HFOV) group 40 cases and conventional mechanical ventilation (CMV) group 36 cases, at the beginning of mechanical ventilation, the two groups began to use the pulmonary surfactant (PS), while HFOV group used intravenous mucosolvan 30 mg/kg daily. The main observation was the comparison of blood gas indicators before and after mechanical ventilator, the indicators changes of related respiratory function and the complication rate, et al. Results PaO2, PaO2/FiO2, Oxygenation index (OI=100×MAP×FiO2/ PaO2) and arterial/alveolar oxygen partial pressure ratio (713×FiO2-PaCO2/0.8) were improved significantly in HFOV group compared with CMV group (P<0.05). There was no statistical significance between both groups in the number of deaths, ventilation time, gas leak syndrome, bronchopulmonary dysplasia (BPD), retinopathy of premature children (ROP), intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL). Conclusion High-frequency oscillatory ventilation mode combined with pulmonary surfactant and mucosolvan could improve arterial blood gas index and respiratory function index and improve oxygenation, it has application value and should be applied extensively.
Pages: 3704-3708
Year: 2015 Issue: 20
Journal: Chinese Journal of Clinicians(Electronic Version)
Keyword: Respiration; artificial; Hyaline membrane disease; High frequency oscillatory ventilation; Pulmonary surfactant; Mucosolvan; Preterm newborns;
Abstract: Objective To investigate the clinical application effect of different ventilation modes combined with pulmonary surfactant and mucosolvan in the treatment of preterm newborns with hyaline membrane disease (HMD). Methods 76 cases of preterm infants with HMD (Ⅲ-Ⅳgrade) from Xuzhou central hospital neonatal intensive care unit (neonatal intensive care unit, NICU) from 2013 January to 2015 February were randomly divided into two group, high frequency oscillatory ventilation (HFOV) group 40 cases and conventional mechanical ventilation (CMV) group 36 cases, at the beginning of mechanical ventilation, the two groups began to use the pulmonary surfactant (PS), while HFOV group used intravenous mucosolvan 30 mg/kg daily. The main observation was the comparison of blood gas indicators before and after mechanical ventilator, the indicators changes of related respiratory function and the complication rate, et al. Results PaO2, PaO2/FiO2, Oxygenation index (OI=100×MAP×FiO2/ PaO2) and arterial/alveolar oxygen partial pressure ratio (713×FiO2-PaCO2/0.8) were improved significantly in HFOV group compared with CMV group (P<0.05). There was no statistical significance between both groups in the number of deaths, ventilation time, gas leak syndrome, bronchopulmonary dysplasia (BPD), retinopathy of premature children (ROP), intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL). Conclusion High-frequency oscillatory ventilation mode combined with pulmonary surfactant and mucosolvan could improve arterial blood gas index and respiratory function index and improve oxygenation, it has application value and should be applied extensively.
Related Articles